U.S. Paper and Forestry Products Stock News

If you are wondering whether West Pharmaceutical Services is fairly priced or offering value right now, looking at a clear, structured view of its valuation can help you decide how it fits into your watchlist. The share price closed at US$248.95, with a 7.7% gain over the last 7 days, while the 1 year return sits at a 22.3% decline and the year to date return is a 9.9% decline. Over the past month, the stock recorded a 9.6% decline, and over 3 and 5 year periods the returns are 7.4% and...

If you are wondering whether Utz Brands at around US$10.98 is a bargain or fairly priced, this article will walk you through what the current share price might be implying. The stock has posted a 4.2% return over the last week and 10.5% over the last month, although it still shows a 6.7% return year to date and a 16.2% decline over the last year, extending to a 29.1% decline over three years and 53.6% over five years. Recent coverage of Utz Brands has focused on the company as a listed snack...

PPG Industries recently reported past fourth-quarter 2025 results showing higher sales of US$3,914 million and a shift from a net loss to net income of US$300 million, alongside securing a sole-supplier refinish coatings agreement with Quality Collision Group’s more than 95 repair centers. Together with new 2026 earnings guidance and the launch of its UL 263-certified, low-VOC PPG STEELGUARD 652 fire protection coating, the company is emphasizing higher-margin technologies and deeper...

Carvana (CVNA) is back in focus after reporting a strong Q3 2025, with higher retail units sold, revenue growth, and record operating income. This performance has led management to offer confident guidance for Q4. See our latest analysis for Carvana. The Q3 update and the recent expansion of same day delivery into the Eugene area come against a backdrop of a volatile share price, with a 25.25% 90 day share price return but a 12.83% decline over 30 days, while total shareholder return over the...

FormFactor (FORM) has drawn fresh attention after releasing record fourth quarter and full year 2025 results, with earnings and revenue ahead of expectations and guidance that points to meaningfully higher first quarter 2026 revenue. See our latest analysis for FormFactor. The earnings beat and upbeat guidance appear to have reset expectations, with FormFactor’s 1 day share price return of 7.65% and 90 day share price return of 68.61% pointing to strong momentum. The 1 year total shareholder...

First Financial Bancorp. recently reported its fourth quarter and full-year 2025 results, showing higher net interest income year on year and full-year net income of US$255.61 million, while also affirming a US$0.25 quarterly dividend and reducing net charge-offs compared with the prior year period. Alongside these results, the bank filed a US$79.29 million shelf registration for 2,753,094 common shares and continued integrating the Westfield acquisition, which boosted deposits and fee...

Two Harbors Investment Corp. recently reported its fourth-quarter and full-year 2025 results, swinging from net income of US$276.73 million in the prior-year quarter to net income of US$11.72 million, and from full-year net income of US$298.17 million to a net loss of US$454.3 million. This reversal also showed up at the per-share level, with earnings from continuing operations turning into basic and diluted losses of US$0.02 for the quarter and US$4.88 for the year, highlighting a sharp...

If you are wondering whether Arbor Realty Trust is priced attractively right now, this article will walk you through what the current share price might be implying about its value. The stock last closed at US$7.80, with returns of 1.3% over the past week, a 3.3% decline over the past month, a 1.9% decline year to date, and a 35.9% decline over the past year, as well as a 23.3% decline over three years and a 13.0% decline over five years. Recent coverage of Arbor Realty Trust has focused on...

Tompkins Financial Corporation reported past fourth-quarter and full-year 2025 results showing higher net interest income and net income versus 2024, with basic earnings per share from continuing operations rising to US$6.74 for the quarter and US$11.30 for the year. Alongside these stronger earnings, the company raised its regular quarterly dividend to US$0.67 per share and completed a small share repurchase program, highlighting a continued focus on returning cash to shareholders despite...

Why Progressive’s earnings and analyst sentiment are pulling investor focus Progressive (PGR) has moved into the spotlight after a strong full year 2025 earnings report coincided with softer analyst expectations for the current quarter and fiscal year, along with a Zacks Rank #4 (Sell). That mix of solid reported results and more cautious forward estimates is creating a gap between what the company just delivered and what some analysts now project. This difference is what many investors are...

BellRing Brands (BRBR) is under pressure after acknowledging that earlier strong sales were tied to retailers stockpiling inventory rather than underlying consumer demand, a disclosure now central to multiple securities class action investigations. See our latest analysis for BellRing Brands. The legal fallout from BellRing's inventory disclosure has gone hand in hand with sharp market repricing, with a 7 day share price return of 21.51% decline and a 1 year total shareholder return of 74.50%...

If you are wondering whether Eli Lilly's current share price still makes sense for new money, the key question is how that price lines up against its underlying value. The stock most recently closed at US$1,058.18, with returns of 2.0% over the last 7 days, a 0.5% decline over 30 days, a 2.1% decline year to date, 21.4% over 1 year, 214.0% over 3 years and a very large gain over 5 years. Recent news coverage around Eli Lilly has largely focused on its position in major treatment areas and...

Apple (AAPL) just delivered a busy start to 2026, with record first quarter results, fresh AI partnerships and regulatory clarity in Europe, giving investors several new data points to assess the stock. See our latest analysis for Apple. Those earnings and AI headlines arrive after a strong run in the stock, with Apple’s 7 day share price return of 7.18% and 30 day return of 7.23% helping push the 1 year total shareholder return to 22.73% and 5 year total shareholder return to 110.74%. This...

Why recent analyst sentiment matters for Freshworks Recent analyst coverage on Freshworks (FRSH) has turned more cautious, as revenue growth is viewed as lagging peers. This raises questions for investors about how to weigh the company’s current performance against its longer term ambitions. See our latest analysis for Freshworks. The cautious analyst tone appears to line up with recent market action, as Freshworks’ share price has a 30 day share price return of 27.12% decline and a 1 year...

If you are wondering whether Sandisk is still worth your attention at current levels, this article will walk through what the recent share price means for its underlying value. Sandisk last closed at US$597.95, after returns of 3.8% over 7 days, 58.4% over 30 days and a very large year to date gain of 117.2%. This naturally raises questions about how the current price lines up with fundamentals. Recent coverage around Sandisk has focused on its role in the broader technology sector and how...

Ionis Pharmaceuticals (IONS) is in focus after a series of drug pipeline milestones, including European Commission approval of Dawnzera, FDA Breakthrough Therapy status for zilganersen, and positive Phase 3 data for bepirovirsen from partner GSK. See our latest analysis for Ionis Pharmaceuticals. The series of regulatory wins and positive trial updates appears to be supporting momentum in Ionis Pharmaceuticals, with a 24.39% 90 day share price return and a very large 1 year total shareholder...

Why Nova’s Metrion win matters for investors Nova (NasdaqGS:NVMI) is in focus after announcing that leading Memory and Logic chip producers have adopted its Nova Metrion platform for Gate All Around and advanced DRAM manufacturing, marking a key commercial milestone in materials metrology. See our latest analysis for Nova. The Metrion announcement lands at a time when Nova’s share price has been strong, with a 1 day share price return of 7.79%, a 30 day share price return of 16.72% and a 90...

If you are wondering whether Arm Holdings' recent share price puts it at a fair level or not, this article will walk through what that current price might mean for value focused investors. The stock recently closed at US$123.70, with returns of 17.4% over the last 7 days and 10.7% over the last 30 days, while the 1 year return sits at a 23.9% decline and the year to date return is 7.8%. Recent news flow around Arm has centered on its position in semiconductor design, licensing and ecosystem...

Recent performance context for Amazon.com (AMZN) Amazon.com (AMZN) has been under pressure recently, with the share price showing negative returns over the past week, month, past 3 months, year to date, and past year, prompting closer attention from investors. See our latest analysis for Amazon.com. With the share price at US$210.32 and a 30 day share price return of a 14.98% decline, recent momentum has clearly faded, even though the 3 year total shareholder return of 115.47% still reflects...

If you are looking at Curtiss-Wright and wondering whether the current share price gives you good value, this article will walk you through what the numbers are actually saying. The stock last closed at US$649.32, with returns of 7.3% over the past 30 days, 13.4% year to date, 83.3% over 1 year and a very large gain over 5 years that is just under 5x. Recent interest in Curtiss-Wright has been shaped by ongoing attention on companies in capital goods and defense related markets, as investors...

Prudential Financial (PRU) is under close watch after voluntarily halting new sales in its Japan business for three months following internal findings of employee misconduct. Management estimates a meaningful hit to 2026 pretax adjusted operating income. See our latest analysis for Prudential Financial. The misconduct issue and Japan sales halt come after a mixed stretch for the stock, with a 7 day share price return of 7.48% and a 30 day share price return of 12.94% decline weighing on...

Niagen Bioscience, Inc. (NASDAQ: NAGE) previously announced it will report fourth quarter and fiscal 2025 results and host an investor conference call on March 4, 2026, including a general business update following the release of its earnings after market close. The company’s position as a leading NAD+ player, with FDA-recognized Niagen® and defended patents around nicotinamide riboside, highlights a reinforced regulatory moat and product pipeline momentum. We’ll now examine how the upcoming...

Why Roper’s latest earnings are getting fresh attention Roper Technologies (ROP) just released fourth quarter and full year 2025 results, showing higher sales but lower net income, along with a completed US$500 million buyback that has investors taking a closer look at the stock. See our latest analysis for Roper Technologies. At a share price of US$362.42, Roper’s 1 month share price return of a 16.65% decline and 3 month share price return of a 19.43% decline point to fading momentum. The 1...

Wondering if Post Holdings at around US$114.61 is offering fair value or a potential bargain, especially after its recent run, is a natural question for anyone watching the stock. The share price performance has been strong recently, with returns of 12.0% over the last 7 days, 15.7% over the last 30 days, 15.0% year to date and 68.0% over 5 years. The 1 year return stands at 1.8% and the 3 year return at 24.9%. Recent attention on Post Holdings has centered on its position within the...